Abstract
Background Previous studies indicate that improved healthcare access through Medicaid expansion and the alleviation of socioeconomic stressors via higher minimum wages lead to improved health outcomes. However, a significant gap remains in examining the distribution of Alzheimer’s disease (AD) dementia in the context of these policies. Thus, this study investigates the spatial relationships between the Medicaid expansion, minimum wage policy, and AD dementia prevalence across the US.
Methods We employed the Getis-Ord Gi* statistic to identify hot spots and cold spots of AD dementia prevalence at the county level across the US. We compared these locations with the county-level overall social vulnerability index (SVI) scores. Moreover, we assessed the proportion of hot and cold spots at the state level based on Medicaid expansion and minimum wage status.
Results Our analysis revealed that the most vulnerable SVI quartile (Q4) had the highest number of hot spots (n=311, 64.8%), while the least vulnerable quartile (Q1) had the fewest hot spots (n=22, 4.6%) (χ2=307.41, P<0.01). Additionally, Q4 had the fewest cold spots (n=54, 11.7%). States that adopted Medicaid expansion had a significantly lower proportion of hot spots compared to non-adopting states (P<0.05), and the non-adopting states had significantly higher odds of having hot spots than adopting states (OR=2.58, 95% CI: 2.04–3.26, P<0.001). Conversely, the non-adopting states had significantly lower odds of having cold spots compared to the adopting states (OR=0.24, 95% CI: 0.19–0.32, P<0.01). States with minimum wage levels at or below the federal level showed significantly higher odds of having hot spots than states with a minimum wage above the federal level (OR=1.94, 95% CI: 1.51–2.49, P<0.01).
Discussion Our findings suggest significant disparities in AD dementia prevalence related to socioeconomic and policy factors and lay the groundwork for future causal analyses to examine whether these policies have impacted disparities in healthcare access for people with AD dementia across the US.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
A.M. and A.V.A. are supported by the South Carolina SmartState Endowed Center for Envi-ronmental and Biomedical Panomics (CEABP); A.V.A. is supported by the South Carolina Cancer Disparities Research Center (SC CADRE) from NIH/NCI U54 CA210962.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author.
